Related Experiment Video

Updated: Jun 28, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors

Bryan R Downie1, Araceli Sánchez, Hendrik Knötgen

  • 1Max-Planck Institute of Experimental Medicine, Hermann-Rein Str. 3, 37075 Göttingen, Germany.

The Journal of Biological Chemistry
|October 18, 2008
PubMed

Insights

Ether-á-go-go-1 (Eag1) channels promote tumor growth independently of ion flow. Eag1 disrupts oxygen balance, boosting tumor vascularization and progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Channelopathies

Background:

  • Ether-á-go-go-1 (Eag1) is a voltage-gated potassium channel.
  • Eag1 is ectopically expressed in many solid tumors, suggesting a role in cancer.
  • The precise mechanisms linking Eag1 to tumor progression are not fully understood.

Purpose of the Study:

  • To investigate the role of Eag1 in tumor progression.
  • To identify the mechanisms by which Eag1 contributes to cancer development.
  • To determine if Eag1's function as an ion channel is essential for its role in tumor growth.

Main Methods:

  • In vivo xenograft tumor formation assays.
  • In vitro cell culture techniques.
  • Utilized a mutated Eag1 channel lacking ion permeation function.

Main Results:

  • A mutated Eag1 channel that cannot conduct ions still supported xenograft tumor formation.
  • Eag1 appears to contribute to tumor progression independently of its ion channel activity.
  • Eag1 interferes with cellular oxygen homeostasis, leading to increased HIF-1 activity.

Conclusions:

  • Eag1 plays a significant role in tumor progression beyond its ion channel function.
  • Eag1's disruption of oxygen homeostasis promotes tumor vascularization via HIF-1 and VEGF.
  • Targeting Eag1 may offer novel therapeutic strategies for solid tumors.

More Related Videos

Induction and Testing of Hypoxia in Cell Culture07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...